This is a heavily interactive web application, and JavaScript is required. Simple HTML interfaces are possible, but that is not what this is.
Post
Podocyte Talk - Dr. Anass Qasem
podocytetalk.bsky.social
did:plc:4ugi2tqiotq2335qigdvgfxk
In IgA nephropathy, dapagliflozin slowed eGFR decline, especially in patients with faster pre-treatment loss. The pre-treatment eGFR slope predicted post-treatment benefit, suggesting value in guiding therapy.
#podocytetalk #CKD #GN #Nephsky
https://www.kireports.org/article/S2468-0249(25)00267-0/fulltext
2025-05-04T07:06:25.482Z